What is Castle Biosciences's other noncash income (expense)?

Castle Biosciences (CSTL) reported other noncash income (expense) of -$532K in Q1 2026.

How has Castle Biosciences's other noncash income (expense) changed year-over-year?

Castle Biosciences's other noncash income (expense) decreased by 1673.3% year-over-year, from -$30K to -$532K.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

Castle Biosciences CSTL Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Personalis, Inc.PSNL

-$21K-106%

Fulgent Genetics, Inc.FLGT

-$1K+95.2%

Adaptive BiotechnologiesADPT

-$14K+81.6%

Mesa LaboratoriesMLAB

-$1.26M+40.8%

Pulse Biosciences, Inc.PLSE

-$62K—

Quest DiagnosticsDGX

——

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's other noncash income (expense)?: Castle Biosciences (CSTL) reported other noncash income (expense) of -$532K in Q1 2026.
How has Castle Biosciences's other noncash income (expense) changed year-over-year?: Castle Biosciences's other noncash income (expense) decreased by 1673.3% year-over-year, from -$30K to -$532K.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.